USAGE OF PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS AND ANTI-CD20 AGENTS TO TREAT HEMATOLOGIC CANCERS

摘要

Present invention relates to hematologic cancers treatment including application of purine nucleoside phosphorylase (PNP) inhibitor combina¬tion with alkylating agent and anti-CD20 agent. Invention also relates to compositions containing said combination, and kit additionally including system supplying such combination.